• Craig S, Khalil M, Eszlinger M, Itani D, Koebel M, Koro K, Minoo P, Ogilvie T, Stewardson P, Teman C, Ziehr B, Pasieka JL. Malignancy is in the eye of the beholder: Pathologic diagnosis of challenging follicular neoplasms in the era of noninvasive follicular thyroid neoplasms with papillary-like nuclear features and immunohistochemical and molecular adjuncts. Surgery. 2021; 169:22-26. doi: 10.1016/j.surg.2020.04.004.
  • Stephenson A, Eszlinger M, Stewardson P, McIntyre JB, Boesenberg E, Bircan R, Sancak S, Gozu HI, Ghaznavi S, Krohn K, Paschke R. Sensitive Sequencing Analysis Suggests Thyrotropin Receptor and Guanine Nucleotide-Binding Protein G Subunit Alpha as Sole Driver Mutations in Hot Thyroid Nodules. Thyroid. 2020; 30:1482-1489. doi: 10.1089/thy.2019.0648.
  • Stephenson A, Lau L, Eszlinger M, Paschke R. The Thyrotropin Receptor Mutation Database Update. Thyroid. 2020; 30:931-935. doi: 10.1089/thy.2019.0807.
  • Haase J, Misiak D, Bauer M, Pazaitis N, Braun J, Pötschke R, Mensch A, Bell JL, Dralle H, Siebolts U, Wickenhauser C, Lorenz K, Hüttelmaier S. IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis. Mod Pathol. 2020; doi: 10.1038/s41379-020-0630-0.
  • Stenzinger A, Endris V, Budczies J, Merkelbach-Bruse S, Kazdal D, Dietmaier W, Pfarr N, Siebolts U, Hummel M, Herold S, Andreas J, Zoche M, Tögel L, Rempel E, Maas J, Merino D, Stewart M, Zaoui K, Schlesner M, Glimm H, Fröhling S, Allen J, Horst D, Baretton G, Wickenhauser C, Tiemann M, Evert M, Moch H, Kirchner T, Büttner R, Schirmacher P, Jung A, Haller F, Weichert W, Dietel M. Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study. J Thorac Oncol. 2020;15:1177-1189. doi: 10.1016/j.jtho.2020.01.023.
  • Heydt C, Rehker J, Pappesch R, Buhl T, Ball M, Siebolts U, Haak A, Lohneis P, Büttner R, Hillmer AM, Merkelbach-Bruse S. Analysis of tumor mutational burden: correlation of five large gene panels with whole exome sequencing Sci Rep. 2020;10:11387. doi: 10.1038/s41598-020-68394-4.
  • Jaeschke H, Undeutsch H, Patyra K, Löf C, Eszlinger M, Khalil M, Jännäri M, Makkonen K, Toppari J, Zhang FP, Poutanen M, Paschke R, Kero J. Hyperthyroidism and Papillary Thyroid Carcinoma in Thyrotropin Receptor D633H Mutant Mice. Thyroid. 2018;28:1372-1386. doi: 10.1089/thy.2018.0041.
  • Eszlinger M, Ullmann M, Ruschenburg I, Böhme K, Görke F, Franzius C, Adam S, Molwitz T, Landvogt C, Amro B, Hach A, Feldmann B, Graf D, Wefer A, Niemann R, Bullmann C, Klaushenke G, Santen R, Tönshoff G, Ivancevic V, Kögler A, Bell E, Lorenz B, Kluge G, Hartenstein C, Paschke R. Low Malignancy Rates in Fine-Needle Aspiration Cytologies in a Primary Care Setting in Germany.Thyroid. 2017;27:1385-1392. doi: 10.1089/thy.2017.0167.
  • Eszlinger M, Böhme K, Ullmann M, Görke F, Siebolts U, Neumann A, Franzius C, Adam S, Molwitz T, Landvogt C, Amro B, Hach A, Feldmann B, Graf D, Wefer A, Niemann R, Bullmann C, Klaushenke G, Santen R, Tönshoff G, Ivancevic V, Kögler A, Bell E, Lorenz B, Kluge G, Hartenstein C, Ruschenburg I, Paschke R. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany. Thyroid. 2017;27:402-411. doi: 10.1089/thy.2016.0445.